Literature DB >> 25286029

miR-106b modulates cancer stem cell characteristics through TGF-β/Smad signaling in CD44-positive gastric cancer cells.

Dayeon Yu1, Hyun-Soo Shin2, Yeo Song Lee1, Yong Chan Lee1.   

Abstract

Cancer stem cells have the capacity to form new tumors and are thus considered to be a cause of metastasis and tumor recurrence. However, many of the mechanisms determining cancer stem cell characteristics are still unknown. MicroRNAs (miRNAs) are possible modulators of cancer stem cell generation and may be involved in the retention of cancer stem cell characteristics. The aim of this study was to examine the miRNA expression profiles regulating the cancer stem-like cell characteristics in gastric cancer. We sorted gastric cancer stem-like cells using the stem cell marker CD44 by fluorescence-activated cell sorting. CD44(+) cells formed more and larger spheres compared with CD44(-) cells. Cancer stem cell markers were overexpressed in CD44(+) cells. CD44(+) cells showed increased expression of mesenchymal cell markers, whereas epithelial markers were downregulated. In miRNA microarray, the miR-106b family comprising miR-106b, miR-93, and miR-25 was significantly upregulated in CD44(+) cells than in CD44(-) cells. Smad7, which inhibits transforming growth factor-β (TGF-β)/Smad signaling as a target of the miR-106b family, was downregulated in CD44(+) cells. Furthermore, expression of TGF-β/Smad signal molecules was activated in CD44(+) cells, in accordance with the action of the miR-106b family. Inhibition of miR-106b showed suppression of the TGF-β/Smad signaling pathway and decreased self-renewal capacity and cell invasiveness. Our study suggests that CD44(+) gastric cancer cells show cancer stem cell properties with epithelial-mesenchymal transition (EMT). Increased miR-106b family expression regulated cancer stem-like cell properties, particularly EMT characteristics, through the TGF-β/Smad signaling pathway in CD44(+) stem-like cells. Taken together, these results indicate that targeting miR-106b may be an effective form of cancer therapy in gastric cancer through the modulation of cancer stem cell characteristics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25286029     DOI: 10.1038/labinvest.2014.125

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  31 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.

Authors:  T Ebisawa; M Fukuchi; G Murakami; T Chiba; K Tanaka; T Imamura; K Miyazono
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

Review 3.  Global patterns of cancer incidence and mortality rates and trends.

Authors:  Ahmedin Jemal; Melissa M Center; Carol DeSantis; Elizabeth M Ward
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

4.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

5.  TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells.

Authors:  Daylon James; Ariel J Levine; Daniel Besser; Ali Hemmati-Brivanlou
Journal:  Development       Date:  2005-02-09       Impact factor: 6.868

6.  Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues.

Authors:  Junming Guo; Ying Miao; Bingxiu Xiao; Rong Huan; Zhen Jiang; Dan Meng; Yanjun Wang
Journal:  J Gastroenterol Hepatol       Date:  2008-11-03       Impact factor: 4.029

7.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

8.  Identification of gastric cancer stem cells using the cell surface marker CD44.

Authors:  Shigeo Takaishi; Tomoyuki Okumura; Shuiping Tu; Sophie S W Wang; Wataru Shibata; Ramanathan Vigneshwaran; Shanisha A K Gordon; Yutaka Shimada; Timothy C Wang
Journal:  Stem Cells       Date:  2009-05       Impact factor: 6.277

9.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

10.  Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer.

Authors:  Young-Kook Kim; Jieun Yu; Tae Su Han; Seong-Yeon Park; Bumjin Namkoong; Dong Hyuk Kim; Keun Hur; Moon-Won Yoo; Hyuk-Joon Lee; Han-Kwang Yang; V Narry Kim
Journal:  Nucleic Acids Res       Date:  2009-01-19       Impact factor: 16.971

View more
  47 in total

1.  Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44.

Authors:  Jun Li; Juan Wei; Zhu Mei; Yongmei Yin; Yongfei Li; Mingjie Lu; Shidai Jin
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

Review 2.  Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?

Authors:  Hidetaka Shima; Akimitsu Yamada; Takashi Ishikawa; Itaru Endo
Journal:  Gland Surg       Date:  2017-02

Review 3.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

4.  Deregulation of miR-93 and miR-143 in human esophageal cancer.

Authors:  Mohammad Hossein Ansari; Shiva Irani; Houri Edalat; Ruhul Amin; Amaneh Mohammadi Roushandeh
Journal:  Tumour Biol       Date:  2015-10-01

5.  A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer.

Authors:  Alireza Ahadi
Journal:  Immunogenetics       Date:  2021-01-05       Impact factor: 2.846

6.  Effects of Lactobacillus casei Strain T2 (IBRC-M10783) on the Modulation of Th17/Treg and Evaluation of miR-155, miR-25, and IDO-1 Expression in a Cuprizone-Induced C57BL/6 Mouse Model of Demyelination.

Authors:  Saeideh Gharehkhani Digehsara; Niloofar Name; Behnaz Esfandiari; Elahe Karim; Saba Taheri; Maryam Tajabadi-Ebrahimi; Javad Arasteh
Journal:  Inflammation       Date:  2020-09-10       Impact factor: 4.092

7.  MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh's esophageal squamous cell carcinoma.

Authors:  Fang Dai; Tao Liu; Shutao Zheng; Qing Liu; Chenchen Yang; Jian Zhou; Yumei Chen; Ilyar Sheyhidin; Xiaomei Lu
Journal:  Tumour Biol       Date:  2016-09-12

8.  MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo.

Authors:  Meng Zhu; Ning Zhang; Shuixiang He; Ruirui Yan; Jun Zhang
Journal:  Clin Exp Metastasis       Date:  2016-05-03       Impact factor: 5.150

Review 9.  Dysregulation of non-coding RNAs in gastric cancer.

Authors:  Qing Yang; Ren-Wen Zhang; Peng-Cheng Sui; Hai-Tao He; Lei Ding
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

10.  HYD-PEP06 suppresses hepatocellular carcinoma metastasis, epithelial-mesenchymal transition and cancer stem cell-like properties by inhibiting PI3K/AKT and WNT/β-catenin signaling activation.

Authors:  Wei Tian; Jiatong Li; Zhuo Wang; Tong Zhang; Ying Han; Yanyan Liu; Wenfeng Chu; Yu Liu; Baofeng Yang
Journal:  Acta Pharm Sin B       Date:  2021-04-02       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.